Perfect Medical Health Management Limited (“Perfect Medical”) submitted its Monthly Return for Equity Issuer to Hong Kong Exchanges and Clearing Limited, covering the period ended 31 October 2026. Key data indicate a stable capital structure with full compliance to listing requirements.

Authorised and Issued Capital • Authorised share capital remained unchanged at 10.00 billion ordinary shares with a par value of HKD 0.10 each, equivalent to HKD 1.00 billion. • Issued share capital was steady at 1.256 billion ordinary shares; no treasury shares were held or cancelled. There were no changes in issued or treasury shares during the month.

Public Float Perfect Medical confirmed adherence to the Main Board’s minimum public float threshold of 25%, indicating sufficient free-float liquidity as at 31 October 2026.

Share Option Schemes • 2021 Share Option Scheme: 11.30 million options outstanding; up to 7.54 million additional shares may be issued under this plan. • 2026 Share Option Scheme: 50.00 million options outstanding; up to 1.50 million additional shares remain issuable. No options were exercised in October, and no funds were raised from option exercises.

Other Equity Instruments The company reported no warrants, convertibles, or other equity-linked instruments outstanding, and no share repurchases or cancellations occurred during the month.

Regulatory Compliance All disclosures were confirmed by the board and the company secretary as compliant with Hong Kong listing rules and relevant legal requirements.